Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

The Food and Drug Administration (FDA) has recently issued two draft guidance documents aimed at providing recommendations for the use of AI ...

XtalPi Holdings, an artificial intelligence (AI) drug discovery firm based in the Greater Bay Area, is changing the ...

On January 6, 2025, the U.S. Food and Drug Administration (FDA) released draft guidance titled Considerations for the Use of Artificial ...

13, 2025 (GLOBE NEWSWIRE) -- “According to SNS Insider, The Artificial Intelligence in Drug Discovery ... immense promise as it accelerates drug development through data-driven decision-making ...

The agency wants applicants to demystify their algorithms and provide specific details about what the models do, how they’re ...

Events and conferences continue to connect Vancouver-based researchers with investors, as governments move money into ...

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.

By Kashmir Hill The maker of ChatGPT hopes to spur investment from the Middle East and avoid strict regulations on the development ... that cutting-edge artificial intelligence is developed ...

VANCOUVER, BC / ACCESS Newswire / January 22, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)("Onco" or the "Company") is pleased to announce that it has entered into a letter of ...